Please use this identifier to cite or link to this item:
Title: Phytopharmacological Investigations of Bioactives from Symplocos Racemosa Bark with specific reference to Anticander Activity
Researcher: Shah Unnati
Guide(s): Acharya Niyati
Keywords: Anticancer
University: Nirma University
Completed Date: 22/04/2016
Abstract: Hepatocellular carcinoma (HCC) is the one of the world s commonest cancer, ranking third with newlinevery high morbidity and mortality rates with poor prognosis. With the increasing incidence of newlineHCC globally, especially in China, Asia, Africa; therapeutic approaches for HCC are very limited newlinecurrently. Therefore, there is an urgent quest for improvement of therapeutic activity and newlineselectivity of anticancer agents or drug combinations from natural source with no or limited newlinetoxicity for developing cancer therapeutics. Considering the continuing need for effective newlineanticancer agents, medicinal plants play inexhaustible source of anticancer drugs in term of both newlinevariety and mechanism of action. Over 50% of anticancer drugs approved by United states Food newlineand Drug Administration, originated from natural resources, especially from terrestrial plants. newlineSymplocos racemosa Roxb. belongs to a unigeneric family Symplocaceae; is a small evergreen newlinetree; found commonly in the plains and hills of northern India and other Asian countries, up to a newlineheight of 1400 m. The bark of S. racemosa has many glycosides, terpenoids, steroids and newlineflavonoids with various pharmacological effects. The ethnobotanical literature indicates the newlineutility of the bark in liver complaints, bowel complaints such as diarrhoea, dysentery and dropsy, newlineskin diseases, ear/eye disease, uterine complaints, vaginal and menstrual disorders, tumors, fever, newlineulcers and scorpion-string bite. In Ayurveda pittaja arbuda and medoja arbuda tumors are newlinereported to be treated with bark of S. racemosa in combination with other drugs. These references newlineprovide the traditional backbone to our objectives to screen the chemoprevention and cytotoxic newlinepotential of bark of S. racemosa. So the aim of the study is to evaluate the anticancer potential of newlinebark of S. racemosa against the hepatocellular carcinoma using in vitro and in vivo method. newline
Appears in Departments:Institute of Pharmacy

Files in This Item:
File Description SizeFormat 
02_certificate.pdfAttached File418.68 kBAdobe PDFView/Open
03_ abstract.pdf199.64 kBAdobe PDFView/Open
04_declaration.pdf592.38 kBAdobe PDFView/Open
05_acknowledgement.pdf100.66 kBAdobe PDFView/Open
06_content.pdf84.71 kBAdobe PDFView/Open
07_list of table.pdf174.47 kBAdobe PDFView/Open
08_list of figure final.pdf144.3 kBAdobe PDFView/Open
09_list of abbreviations.pdf179.65 kBAdobe PDFView/Open
10_chapter 1.pdf295.44 kBAdobe PDFView/Open
11_chapter 2.pdf928.12 kBAdobe PDFView/Open
12_chapter 3.pdf186.17 kBAdobe PDFView/Open
13_chapter 4.pdf562.31 kBAdobe PDFView/Open
14_ chapter 5.pdf385.3 kBAdobe PDFView/Open
15_chapter 6.pdf1.94 MBAdobe PDFView/Open
16_chapter 7.pdf871.17 kBAdobe PDFView/Open
17_chapter 8.pdf413.33 kBAdobe PDFView/Open
18_conclusion & summary.pdf179.74 kBAdobe PDFView/Open
19_future scope.pdf138.76 kBAdobe PDFView/Open
1_title.pdf126.73 kBAdobe PDFView/Open
20_bibliography.pdf288.07 kBAdobe PDFView/Open
21_appendix.pdf3.55 MBAdobe PDFView/Open
Show full item record

Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).

Altmetric Badge: